DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,116,450 | -8.8% | 4,500 | -11.8% | 0.05% | -4.0% |
| Q2 2023 | $1,224,000 | -0.9% | 5,100 | +4.1% | 0.05% | -2.0% |
| Q1 2023 | $1,234,996 | +365.3% | 4,900 | +390.0% | 0.05% | +325.0% |
| Q4 2022 | $265,420 | -48.7% | 1,000 | -50.0% | 0.01% | -29.4% |
| Q3 2022 | $517,000 | -29.7% | 2,000 | -31.0% | 0.02% | -26.1% |
| Q2 2022 | $735,000 | -13.6% | 2,900 | 0.0% | 0.02% | +4.5% |
| Q1 2022 | $851,000 | +115.4% | 2,900 | +141.7% | 0.02% | +120.0% |
| Q4 2021 | $395,000 | +65.3% | 1,200 | -45.5% | 0.01% | +11.1% |
| Q3 2018 | $239,000 | +10.1% | 2,200 | 0.0% | 0.01% | +12.5% |
| Q2 2018 | $217,000 | -38.2% | 2,200 | -51.1% | 0.01% | -38.5% |
| Q4 2016 | $351,000 | -33.1% | 4,500 | -32.8% | 0.01% | -35.0% |
| Q3 2016 | $525,000 | -13.4% | 6,700 | +11.7% | 0.02% | -20.0% |
| Q2 2016 | $606,000 | +127.8% | 6,000 | +114.3% | 0.02% | +127.3% |
| Q1 2016 | $266,000 | – | 2,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |